Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH VENUS REMEDIES PROCTER & GAMBLE HEALTH/
VENUS REMEDIES
 
P/E (TTM) x 35.6 15.0 236.9% View Chart
P/BV x 10.9 0.9 1,145.6% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   VENUS REMEDIES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
VENUS REMEDIES
Mar-23
PROCTER & GAMBLE HEALTH/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs5,366379 1,416.1%   
Low Rs3,883145 2,677.9%   
Sales per share (Unadj.) Rs740.7415.5 178.3%  
Earnings per share (Unadj.) Rs138.219.9 695.7%  
Cash flow per share (Unadj.) Rs155.244.0 352.4%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6344.3 130.0%  
Shares outstanding (eoy) m16.6013.37 124.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.20.6 990.4%   
Avg P/E ratio x33.513.2 253.8%  
P/CF ratio (eoy) x29.85.9 501.0%  
Price / Book Value ratio x10.30.8 1,358.1%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,7613,501 2,192.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,062570 361.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,2965,555 221.3%  
Other income Rs m184103 178.2%   
Total revenues Rs m12,4805,658 220.6%   
Gross profit Rs m3,247602 539.3%  
Depreciation Rs m281323 87.0%   
Interest Rs m83 261.9%   
Profit before tax Rs m3,142379 828.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847114 745.5%   
Profit after tax Rs m2,295266 863.8%  
Gross profit margin %26.410.8 243.7%  
Effective tax rate %27.030.0 90.0%   
Net profit margin %18.74.8 390.2%  
BALANCE SHEET DATA
Current assets Rs m11,7133,230 362.7%   
Current liabilities Rs m6,791826 822.4%   
Net working cap to sales %40.043.3 92.5%  
Current ratio x1.73.9 44.1%  
Inventory Days Days26337 711.7%  
Debtors Days Days343504 68.2%  
Net fixed assets Rs m10,6172,781 381.7%   
Share capital Rs m166134 124.2%   
"Free" reserves Rs m7,2654,470 162.5%   
Net worth Rs m7,4314,603 161.4%   
Long term debt Rs m0387 0.0%   
Total assets Rs m22,3306,011 371.5%  
Interest coverage x409.1130.0 314.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.9 59.6%   
Return on assets %10.34.5 230.7%  
Return on equity %30.95.8 535.1%  
Return on capital %42.47.7 553.4%  
Exports to sales %00-   
Imports to sales %13.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,605NA-   
Fx inflow Rs m1,4650-   
Fx outflow Rs m1,6050-   
Net fx Rs m-1400-   
CASH FLOW
From Operations Rs m2,360366 644.3%  
From Investments Rs m-215-508 42.3%  
From Financial Activity Rs m-985-6 17,336.3%  
Net Cashflow Rs m1,160-220 -526.4%  

Share Holding

Indian Promoters % 0.0 41.8 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.3 1.6 1,274.2%  
FIIs % 7.6 1.6 478.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 58.2 82.7%  
Shareholders   56,730 19,560 290.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs VENUS REMEDIES Share Price Performance

Period Procter & Gamble Health VENUS REMEDIES S&P BSE HEALTHCARE
1-Day -0.64% 0.25% -0.89%
1-Month -3.44% -6.93% -4.95%
1-Year -1.20% 107.21% 57.58%
3-Year CAGR -8.96% 6.33% 18.17%
5-Year CAGR 7.96% 56.73% 18.90%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.